---
title: "Second PIC/S GMP Certification | Mabwell Passes Brazilian GMP Inspection for Its Denosumab Injections"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295342144.md"
description: "On August 9, 2026, in Shanghai, an innovation-focused biopharmaceutical company named Mabwell, listed as 688062 on the Shanghai Stock Exchange and 02493 on the Hong Kong Stock Exchange, revealed that its subsidiary T-mab has cleared the Good Manufacturing Practice (GMP) inspection conducted by the Brazilian Health Regulatory Agency (ANVISA). This accomplishment signifies a major milestone for the company's operations in Brazil."
datetime: "2026-08-10T00:48:44.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295342144.md)
  - [en](https://longbridge.com/en/news/295342144.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295342144.md)
generator: "portal-rs"
---

# Second PIC/S GMP Certification | Mabwell Passes Brazilian GMP Inspection for Its Denosumab Injections

On August 9, 2026, in Shanghai, an innovation-focused biopharmaceutical company named Mabwell, listed as 688062 on the Shanghai Stock Exchange and 02493 on the Hong Kong Stock Exchange, revealed that its subsidiary T-mab has cleared the Good Manufacturing Practice (GMP) inspection conducted by the Brazilian Health Regulatory Agency (ANVISA). This accomplishment signifies a major milestone for the company's operations in Brazil.

### Related Stocks

- [02493.HK](https://longbridge.com/en/quote/02493.HK.md)
- [688062.CN](https://longbridge.com/en/quote/688062.CN.md)

## Related News & Research

- [Mabwell reports Phase Ib/IIa data showing anti-ST2 antibody 9MW1911 cuts COPD exacerbations up to 81%](https://longbridge.com/en/news/298042457.md)
- [Mabwell Reports Positive COPD Data for 9MW1911 Ahead of ERS 2026](https://longbridge.com/en/news/298058989.md)
- [Mabwell Sets Board Meeting to Approve 2026 Interim Results](https://longbridge.com/en/news/296331890.md)
- [Ocumension says China regulator accepts domestic filing for dexamethasone eye injection OT-502](https://longbridge.com/en/news/297648398.md)
- [Mabwell passes Brazil ANVISA GMP inspection for denosumab biosimilars](https://longbridge.com/en/news/295337739.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**